Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression

Journal

Journal of Microbiology, Immunology and Infection

Journal Volume

52

Journal Issue

6

Pages

865-871

Date Issued

2019

Author(s)

Hung T.-C.

Chen G.-J.

Cheng S.-H.

Chen J.-H.

Wei J.-L.

Cheng C.-Y.

CHIEN-CHING HUNG

DOI

10.1016/j.jmii.2019.07.002

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070541055&doi=10.1016%2fj.jmii.2019.07.002&partnerID=40&md5=deba57f2494c57ec0480fcac90c9c7a9

https://scholars.lib.ntu.edu.tw/handle/123456789/588729

SDGs

[SDGs]SDG3

Publisher

Elsevier Ltd

Type

journal article